Related Experiment Videos
[Elimination of CD28+ T cell in patients with chronic active hepatitis]
Insights
T-cell responses are crucial in hepatitis. Researchers found decreased CD28+ T cells in active hepatitis, suggesting the B7-CD28 pathway
Area of Science:
- Immunology
- Hepatology
- Cellular Biology
Background:
- Hepatitis involves complex immune responses.
- T-cells play a significant role in liver inflammation and injury.
Purpose of the Study:
- To investigate the function of cytotoxic T-cells in active hepatitis.
- To analyze the CD28+ T-cell population in hepatitis patients.
Main Methods:
- Flow cytometry was used to examine CD28+ T-cells.
- Patients with chronic active hepatitis, remission hepatitis, liver cirrhosis, and heptoma were studied.
- Comparison was made with normal controls.
Main Results:
- A significant decrease in CD28+ T-cells and CD8+CD28+ T-cells was observed in patients with chronic active hepatitis.
- This reduction was notable when compared to healthy individuals, liver cirrhosis patients, and heptoma patients.
Conclusions:
- The findings suggest that the B7-CD28 costimulatory pathway is implicated in hepatitis-related tissue damage.
- This pathway may represent a therapeutic target for managing hepatitis.
Abstract
Objective:
To study the role of toxicyte T cell in active hepatitis.
Methods:
We examined CD28+ T cell in patients with chronic active/remission hepatitis by flow cytometry.
Results:
It shows that CD28+, CD8+CD28+ T cell in patients with chronic active hepatitis decreased significantly, compared with normal control or patients with liver cirrhosis and heptoma.
Conclusion:
It implies that B7-CD28 costimulation pathway contribute to the tissue injury in hepatitis.